|
Ramos-Molina B, Lick AN, Blanco EH, Posada-Salgado JA, Martinez-Mayorga K, Johnson AT, Jiao GS, Lindberg I. Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays. Biochem Pharmacol. 2015 Jul 15;96(2):107-18. doi: 10.1016/j.bcp.2015.05.008. Epub 2015 May 21. PubMed PMID: 26003844; PubMed Central PMCID: PMC4468025.
AÑO: 2015; IF: 4.96
|
26003844
|
Ramos-Molina B, López-Contreras AJ, Lambertos A, Dardonville C, Cremades A, Peñafiel R. Influence of ornithine decarboxylase antizymes and antizyme inhibitors on agmatine uptake by mammalian cells. Amino Acids. 2015 May;47(5):1025-34. doi: 10.1007/s00726-015-1931-3. PubMed PMID: 25655388.
AÑO: 2015; IF: 3.063
|
|
Ramos-Molina B, Lindberg I. Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation. Mol Endocrinol. 2015 May;29(5):756-64. doi: 10.1210/me.2014-1394. Epub 2015 Mar 26. PubMed PMID: 25811241; PubMed Central PMCID: PMC4415208.
AÑO: 2015; IF: 3.678
|
|
Blanco EH, Ramos-Molina B, Lindberg I. Revisiting PC1/3 Mutants: Dominant-Negative Effect of Endoplasmic Reticulum-Retained Mutants. Endocrinology. 2015 Oct;156(10):3625-37. doi: 10.1210/en.2015-1068. Epub 2015 Jul 24. PubMed PMID: 26207343; PubMed Central PMCID: PMC4588832.
AÑO: 2015; IF: 3.961
|
|
Ramos-Molina B, Lambertos A, Lopez-Contreras AJ, Kasprzak JM, Czerwoniec A, Bujnicki JM, Cremades A, Peñafiel R. Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2. FEBS Open Bio. 2014 Jun 2;4:510-21. doi: 10.1016/j.fob.2014.05.004. PubMed PMID: 24967154; PubMed Central PMCID: PMC4066113.
AÑO: 2014; IF: 2.231
|